Roche OTC Unit Gives Bayer Some Cash Insurance In Wake Of Baycol
This article was originally published in The Tan Sheet
Executive Summary
The addition of Roche's OTC unit may provide Bayer with a consistent cash generator as insurance against fallout from the withdrawal of its cholesterol-lowering drugBaycol (cerivastatin)